Key result
Mediastinal radiation therapy increases the risk of developing radiation-induced valvular heart disease, which presents after a prolonged latent period and requires careful monitoring and management.
Why the study?
Radiation therapy for tumors near the heart can lead to radiation-induced valvular heart disease alongside other cardiovascular pathologies.
Answers are grounded in this paper and cite their sources.
Mediastinal radiation therapy increases the risk of delayed radiation-induced valvular heart disease, underscoring the importance of long-term echocardiographic surveillance and multidisciplinary management.
Anticancer therapy has the potential to cause unwanted cardiovascular side effects. Utilization of radiation therapy to treat tumors near the heart can result in radiation-induced valvular heart disease among other cardiovascular pathologies. The aim of this review is to describe the epidemiology, pathophysiology, risk prediction, non-invasive imaging modalities and management of radiation-induced valvular heart disease with a focus on pre-operative risk assessment and contemporary treatment options.
No takes yet. Share an insight, caveat, or question.
Patil et al. (2022) conducted a review in Radiation-induced valvular heart disease. Mediastinal irradiation was evaluated. Mediastinal radiation therapy increases the risk of developing radiation-induced valvular heart disease, which presents after a prolonged latent period and requires careful monitoring and management.
Synapse has enriched 10 related papers. Consider them for comparative context: